Torys

Torys is distinguished by its focus on the medical cannabis sphere, where sources commend its ‘specialist knowledge of the area’. Combining strength in transactional matters with broad regulatory experience, the group is equipped to handle the full life cycle of industry issues for a mix of crown organizations, blue-chip companies and start-ups. Group head Eileen McMahon chairs both the intellectual property, and the food and drug regulatory practices and contributes deep regulatory expertise; she recently paired up with the real estate group to advise Hawthorne Canada on its acquisition of its Kelowna research facility. Teresa Reguly is also noted. Former department co-head Cheryl Reicin joined Mintz.